logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Dai-Hong Liu

school of medicine
H指数:41
被引数:7,054

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic-drug-monitoring-based ATG Targeted Dosing Strategy in Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation: a randomized, multicenter, phase 3 clinical trial

基于治疗药物监测的ATG靶向给药策略在未处理的单倍型造血干细胞移植中的应用：一项随机、多中心、III期临床试验

Cancer Letters
IF10.1
2026-07-270
PRE
Liping Dou; Nan Wang; Haoyang Zhang; Jingjing Yang; Jishan Du; Qingyang Liu; Xiawei Zhang; Fei Li; Jaap Jan Boelens; Haitao Wang; Weijie Cao; Xiaohui Zhang; Daihong Liu
Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial

低剂量巴瑞替尼联合达那唑治疗原发性免疫性血小板减少症：一项随机对照2期临床试验

Nature Communications
IF15.7
2026-07-250
OAAI
Peng Zhao; Zhuo-Yu An; Hai-Xia Fu; Yang Wang; Guo-Shuang Feng; Hui-Xin Liu; Dai-Hong Liu; Yi Liu; He-Bing Zhou; Hui Liu; Zhao Wang; Yu-Jun Dong; Hong-Mei Jing; Zhen-Ling Li; Li-Hong Li; Li-Ping Dou; Qiu-Sha Huang; Jin Wu; Li-Ping Yang; Yue Jin; Zhi-Xue Li; Chen-Cong Wang; Qi Chen; Xiao-Lu Zhu; Yun He; Yuan-Yuan Zhang; Qian Jiang; Hao Jiang; Jin Lu; Ying-Jun Chang; Xiang-Yu Zhao; Xiao-Jun Huang; Xiao-Hui Zhang
Impact of Concurrent Genetic Alterations on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes

TP53突变急性髓系白血病和骨髓增生异常综合征异基因造血干细胞移植后并发基因改变对预后的影响

Cancer Letters
IF10.1
2026-07-100
PRE
Yao Sun; Jing Liu; Jia Chen; Li Xuan; Jia Liu; Meng-Lin Fan; Sheng-Ye Lu; Lan-Ping Xu; Xi Zhang; Qi-Fa Liu; De-Pei Wu; Xiao-Jun Huang; Dai-Hong Liu
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT

异基因造血细胞移植后出血性膀胱炎的发病率和结局：EBMT传染病工作组的一项调查

Bone Marrow Transplantation
IF5.2
2026-03-260
PRE
Simone Cesaro; Chiara Garonzi; Gloria Tridello; Inge Verheggen; Daihong Liu; Catherine Flynn; Ali AlAhmari; Leylagul Kaynar; Werner Rabitsch; Vedat Uygun; Pedro Chorão; Jiong Hu; Albert Esquirol; Jose Luis Piñana; Mahmoud Aljurf; Eva Wagner-Drouet; Peter Lang; Guillermo Martin-Sanchez; Siret Ratip; Luca Facchini; Barbara Nasilowska-Adamska; Jan Styczynski; Ron Ram; Elisabetta Metafuni; Alina Tanase; Krzysztof Kalwak; Bianca Serio; Hasan Hashem; Luca Castagna; Marta Gonzalez Vicent; Musa Karakukcu; Khaled Halahleh; Ioannis Baltadakis; Edoardo Benedetti; Malgorzata Mikulska; Rafael de la Camara; Dina Averbuch
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry
CLINICAL TRANSPLANTATION
IF1.9
2025-10-260
PRE
Zhao, Xin; Zhou, Ming; Ye, Bao-Dong; Jiang, Er-Lie; Liu, Dai-Hong; Lu, Peihua; Zhou, Fang; Ou-Yang, Gui-Fang; Xu, Ya-Jing; Li, Xin; Qin, Wei-Wei; Yi, Hai; Bai, Guan-Chen; Sun, Zi-Min; Zhang, Xue-Jun; Ran, Xue-Hong; Zhang, Jian-Ping; Su, Guo-Hong; Huang, Jin-Xiong; Xiao, Tai-Wu; Song, Xian-Min; Liu, Hui-Xia; Yan, Jin-Song; Bi, Ke-Hong; Zhang, Xi; Huang, Xiao-Jun; Wang, Shun-Qing; Xu, Lan-Ping
Ruxolitinib and decitabine plus a busulfan–cyclophosphamide conditioning regimen for relapse prophylaxis in patients with high-risk acute myeloid leukemia or myelodysplastic syndromes

鲁索利替尼和地西他滨联合白消安–环磷酰胺预处理方案，用于高危急性髓系白血病或骨髓增生异常综合征患者的复发预防。

Frontiers in Immunology
IF5.9
2025-08-190
OA
Yujun Wei†; Songhua Luan†; Lu Wang†; Lili Wang; Fei Li; Xiangshu Jin; Ruoling Yang; Kun Qian; Bo Peng; Jingwen Tang; Haoyang Zhang; Liping Dou; Daihong Liu
A pragmatic monitoring model for risk of non-relapse mortality based on biomarkers in patients undergoing allogeneic haematopoietic stem-cell transplantation

基于生物标志物的异基因造血干细胞移植患者非复发死亡率风险实用监测模型

British Journal of Haematology
IF3.8
2025-08-110
PRE
Yangliu Shao; Jingjing Yang; Xiaobo Li; Yuqi He; Di Guan; Ri Xu; Lili Miao; Jianyun Wen; Xiaoqin Feng; Tong Wu; Fan Yang; Zeliang Song; Rong Liu; Dao Wang; Zhijie Wei; Jingbo Wang; Xiangjun Liu; Yuelin He; Liping Dou; Daihong Liu
Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: A CBMTR Registry-based propensity score matching analysis over the last decade

HLA相合与半相合造血干细胞移植治疗40-50岁重型再生障碍性贫血患者的可比生存结局：一项基于CBMTR登记数据的近十年倾向性评分匹配分析

CANCER LETTERS
IF10.1
2025-07-010
PRE
Xu, Zheng-Li; Zhang, Yu-Ping; Ye, Bao-dong; Zhao, Xin; Zhou, Ming; Lu, Pei-Hua; Sun, Zi-Min; Li, Xin; Jiang, Er-Lie; Liu, Dai-Hong; Xu, Ya-Jing; Zhou, Fang; Liu, Li; Zhang, Xi; Song, Xian-Min; Zhang, Jian-Ping; Yi, Hai; Zhang, Xue-Jun; Ran, Xue-Hong; Su, Guo-Hong; Zhang, Yan-Ming; Chen, Jie-Ping; Huang, Jin-Xiong; Wang, Chun; Yang, Hai-Ping; He, Peng-Cheng; Su, Nan; Guo, Zi-Wen; Wu, Tong; Bai, Guan-Chen; Fan, Sheng-Jin; Huang, Xiao-Jun; Wang, Shun-Qing; Xu, Lan-Ping
Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40–50: a retrospective analysis from the CBMTR over the past decade

40～50岁复发或难治性严重再生障碍性贫血患者中，后代和匹配无亲缘关系供者移植的临床结局：来自CBMTR过去十年的回顾性分析

Bone Marrow Transplantation
IF5.2
2025-06-170
PRE
Xin Zhao; Yu-Ping Zhang; Bao-Dong Ye; Pei-Hua Lu; Jie-Ping Chen; Jian-Ping Zhang; Xin Li; Guo-Hong Su; Yan-Ming Zhang; Er-Lie Jiang; Fang Zhou; Dai-Hong Liu; Zi-Min Sun; Wei-Wei Qin; Hai Yi; Xue-Hong Ran; Ya-Jing Xu; Xi Zhang; Xiao-Jun Huang; Shun-Qing Wang; Lan-Ping Xu
Updates from a single-center phase 2 study of PD-1 inhibitor combined with hypomethylating agent plus CAG regimen in patients with relapsed/refractory acute myeloid leukemia

单中心PD-1抑制剂联合去甲基化药物与CAG方案治疗复发/难治急性髓系白血病患者的2期研究更新。

FRONTIERS IN IMMUNOLOGY
IF5.9
2025-04-170
OA
Zhou, Hui-Sheng; Su, Yong-Feng; Wang, Jun; Hu, Ya-Lei; Wang, An; Xu, Lei; Wang, Yi-Zhi; Zheng, Xuan; Li, Yu-Qing; Min, Kai-Li; Gao, Chun-Ji; Liu, Dai-Hong
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update

中国异基因造血干细胞移植后白血病复发监测、治疗和预防共识: 2024更新

CANCER LETTERS
IF10.1
2024-11-012
PRE
Wang, Yu; Chang, Ying-Jun; Chen, Jing; Han, Mingzhe; Hu, Jianda; Hu, Jiong; Huang, He; Lai, Yongrong; Liu, Daihong; Liu, Qifa; Luo, Yi; Jiang, Er-lie; Jiang, Ming; Song, Yongping; Tang, Xiao-Wen; Wu, Depei; Xia, Ling-Hui; Xu, Kailin; Zhang, Xi; Zhang, Xiao-Hui; Huang, Xiaojun

研究方向

暂未获取到该数据
黄
黄晓君
H 指数:86论文数:2,129被引数:3.6万
L
Lan‐Ping Xu
H 指数:0论文数:9被引数:0
K
Kai‐Yan Liu
H 指数:53论文数:731被引数:1.3万
Y
Yu‐Hong Chen
H 指数:43论文数:436被引数:7,826
L
Liping Dou
H 指数:20论文数:197被引数:1,531
王昱 封面图
王昱
H 指数:58论文数:802被引数:1.4万
张
张晓慧
H 指数:64论文数:1,343被引数:2.2万
陈欢 封面图
陈欢
H 指数:65论文数:1,120被引数:2.1万
李
李飞
H 指数:27论文数:348被引数:2,637
高晓宁 封面图
高晓宁
H 指数:19论文数:103被引数:1,352